Blog Post By Roberto Viola.
The proposed Regulation on Health Technology Assessment (HTA) covers new medicines and certain new medical devices, providing the basis for permanent and sustainable cooperation at the EU level for joint clinical assessments in these areas.
Concerning the proposal on health technology assessment.
A summary of the debate is now available.
Abnormal heart rhythm is a major cause of cardiovascular disease and death in Europe. An EU-supported programme has made several advances in wearable technology to more comfortably monitor the heart over longer periods, in the hope of saving lives and cutting treatment costs.